Literature DB >> 10351930

Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group.

O R Luhr1, K Antonsen, M Karlsson, S Aardal, A Thorsteinsson, C G Frostell, J Bonde.   

Abstract

To determine the incidence and 90-d mortality of acute respiratory failure (ARF), acute lung injury (ALI), and the acute respiratory distress syndrome (ARDS), we carried out an 8-wk prospective cohort study in Sweden, Denmark, and Iceland. All intensive care unit (ICU) admissions (n = 13,346) >/= 15 yr of age were assessed between October 6th and November 30th, 1997 in 132 of 150 ICUs with resources to treat patients with intubation and mechanical ventilation (I + MV) >/= 24 h. ARF was defined as I + MV >/= 24 h. ALI and ARDS were defined using criteria recommended by the American-European Consensus Conference on ARDS. Calculation to correct the incidence for unidentified subjects from nonparticipating ICUs was made. No correction for in- or out-migration from the study area was possible. The population in the three countries >/= 15 yr of age was 11.74 million. One thousand two hundred thirty-one ARF patients were included, 287 ALI and 221 ARDS patients were identified. The incidences were for ARF 77.6, for ALI 17.9, and for ARDS 13.5 patients per 100,000/yr. Ninety-day mortality was 41.0% for ARF, including ALI and ARDS patients, 42.2% for ALI not fulfilling ARDS criteria, and 41.2% for ARDS.

Entities:  

Mesh:

Year:  1999        PMID: 10351930     DOI: 10.1164/ajrccm.159.6.9808136

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  114 in total

Review 1.  The pulmonary physician in critical care. 5: Acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology.

Authors:  K Atabai; M A Matthay
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 2.  The epidemiologist in the intensive care unit.

Authors:  Gordon D Rubenfeld; Jason D Christie
Journal:  Intensive Care Med       Date:  2003-11-28       Impact factor: 17.440

3.  Health status after critical illness: beyond descriptive studies.

Authors:  Gordon D Rubenfeld; J Randall Curtis
Journal:  Intensive Care Med       Date:  2003-10       Impact factor: 17.440

4.  Optimizing outcomes for older patients treated in the intensive care unit.

Authors:  E Wesley Ely
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

5.  Hyperosmolarity enhances the lung capillary barrier.

Authors:  Zeenat Safdar; Ping Wang; Hideo Ichimura; Andrew C Issekutz; Sadiqa Quadri; Jahar Bhattacharya
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

6.  The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation.

Authors:  Jesús Villar; Jesús Blanco; José Manuel Añón; Antonio Santos-Bouza; Lluís Blanch; Alfonso Ambrós; Francisco Gandía; Demetrio Carriedo; Fernando Mosteiro; Santiago Basaldúa; Rosa Lidia Fernández; Robert M Kacmarek
Journal:  Intensive Care Med       Date:  2011-10-14       Impact factor: 17.440

7.  Are we ready to accept the Berlin definition of acute respiratory distress syndrome for use in children?

Authors:  Robinder G Khemani; Lincoln Smith
Journal:  Crit Care Med       Date:  2015-05       Impact factor: 7.598

8.  Epidemiological trends in invasive mechanical ventilation in the United States: A population-based study.

Authors:  Anuj B Mehta; Sohera N Syeda; Renda Soylemez Wiener; Allan J Walkey
Journal:  J Crit Care       Date:  2015-07-16       Impact factor: 3.425

9.  Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure.

Authors:  Allan J Walkey; Todd W Rice; Jason Konter; Noriyuki Ouchi; Rei Shibata; Kenneth Walsh; Bennett P deBoisblanc; Ross Summer
Journal:  Crit Care Med       Date:  2010-12       Impact factor: 7.598

10.  Ventilatory strategies in patients with sepsis and respiratory failure.

Authors:  Dean R Hess; B Taylor Thompson
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.